TIANJIN PHARMACN MEDICAL TECHNOLOGY CO.,LTD.

Business Type:Manufacturer

Main Products:Cabozantinib,Linezolid,Osimertinib(AZD9291),Palbociclib ,Sorafenib tosylate,Empagliflozin,Vildagliptin,Fluoromethalone,Alectinib,Parecoxib

Country/Region:China

Year Established:2008

Main Markets:North America,Mid East,Eastern Asia,

Ddu Verified

HOT Rank

8/10
Company Information

 TIANJIN PHARMACN MEDICAL TECHNOLOGY CO., LTD. is a high-tech driven enterprise, established in Aug.2008. The company is dedicated to developing and manufacturing Anti-Tumor, Anti-Diabetes and Anti-Cardiovascular APIs and intermediates.

      Tianjin Pharmacn possesses R&D center, standard experiment center, small GMP lab and two plants. The R&D center is located in High-tech Development Zone, covering an area of 1200 m2. Two plants respectively located in Tianjin Dagang Chemical Industrial Park with area of 30 hectares and Jinghai Pharmaceutical Industrial Park (Under construction with GMP standard) with area of 35 hectares.

Tianjin Pharmacn has 50 sets of reactors from 100L to 5000L, with annual production capacity of 300MT, which can conduct -100 ~ 240 ℃ low and high temperature reactions, 0 ~ 5MPa catalytic reactions, and anhydrous oxygen free reactions. Besides of synthesis of Heterocyclic compounds,we also provide technical services of impurity tracking, stability analysis and composition of CTD files.

          Tianjin Pharmacn established a complete Quality Control System, and passed ISO9001 certification in 2012. Keep developing for many years, we have set up reliable business relationship with global customers. Welcome to do cooperation with us.


Email to this supplier
To

Send

Inquiry Cart(0)